Texas woman sues taco chain after finding a cow’s tooth in her to-go order ‘Her reaction was disgust. ‘What is this?’ the woman’s lawyer said The Independent UK · Oct 16
What to Expect From Kenvue's Next Quarterly Earnings Report Kenvue is set to announce its third-quarter results soon, and analysts expect its bottom line to remain unchanged. Barchart · Oct 15
Texas agriculture commissioner 2026: Who is running and what you need to know Agriculture is the state's second largest industry. Here’s a look at the 2026 midterm candidates to oversee the agriculture department and where they stand on the issues. The Texas Tribune · Sep 24
ICE Agent Shoots and Wounds Man in Austin After Reportedly Ramming His Car as Lawmaker Demands Bodycam Footage An ICE agent shot and wounded a man in Austin after a reported vehicle confrontation, prompting calls for an independent investigation and the release of body-camera footage. International Business Times UK · Sep 20
Is Kenvue Underperforming the Nasdaq? Kenvue stock has lagged the broader market over the past year, although analysts remain neutral on the company’s future prospects. Barchart · Sep 12
What Are Wall Street Analysts' Target Price for Kenvue Stock? Kenvue has lagged the broader market over the past year, leaving analysts with a measured view on the stock. Barchart · Jul 29
Is Kenvue Stock Underperforming the S&P 500? Kenvue has lagged the S&P 500 Index over the past year, and analysts remain unsure on the stock’s growth prospects. Barchart · Jun 10
Kenvue Stock: Is Wall Street Bullish or Bearish? Kenvue has underperformed the broader market over the past year, and analysts remain skeptical about the stock’s prospects. Barchart · Apr 28
Here's What to Expect From Kenvue's Next Earnings Report Kenvue will release its first-quarter earnings soon, and analysts anticipate a double-digit bottom-line growth. Barchart · Apr 22
Skip the 10-Year Bond? 3 Dividend Aristocrats to Consider Now Three Dividend Aristocrats offer yields above the 10-year Treasury while delivering income growth and potential capital appreciation MarketBeat · Apr 16
How Is Kenvue’s Stock Performance Compared to Other Consumer Staple Stocks? While recent performance trails the industry, Kenvue continues to retain measured analyst confidence and long-term relevance. Barchart · Mar 11
Kenvue Is Headed for a Merger Vote on January 29. How Should You Play KVUE Stock Here? KVUE stock could gain 15% this week if the potential merger with Kimberly-Clark is approved by all major stakeholders. Barchart · Jan 28
Kenvue Stock: Analyst Estimates & Ratings As Kenvue has underperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook about the stock’s prospects. Barchart · Jan 28
Earnings Preview: What to Expect From Kenvue’s Report Kenvue is gearing to release its fourth-quarter results shortly, and analysts expect its earnings to fall in low-double-digits. Barchart · Jan 9
MarketBeat · Jan 1 Insider Buying: Smart Money Just Spent +$100M on These 3 Stocks Institutional insiders are placing big bets on DASH, KVUE, and KYMR. See how much is being spent on these three stocks and which investors are buying.
Barchart · Dec 5, 2025 Kenvue Stock: Is KVUE Underperforming the Consumer Defensive Sector? As Kenvue has performed weaker than the consumer defensive sector over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.
Benzinga · Nov 17, 2025 Court Rejects Bid To Block Kenvue's $398 Million Shareholder Payout In Tylenol Safety Dispute On Friday, a Texas judge declined to halt an upcoming shareholder payout by Texas Attorney General Ken Paxton to restrict Kenvue Inc.'s (NYSE:KVUE) handling and marketing of Tylenol amid ongoing litigation over the product's safety for pregnant women.
Benzinga · Nov 4, 2025 Kenvue's $48.7 Billion Sale Puts Consumer Staples ETFs Back In Vogue Consumer staples ETFs, usually the quiet corner of the market, are suddenly in the spotlight. The $48.7 billion acquisition of Kenvue Inc. (NYSE:KVUE) by Kimberly-Clark Corp (NASDAQ:KMB) has stirred renewed interest in the sector, setting up a potential reshuffling of weightings across several big-name ETFs.
Kiplinger · Nov 3, 2025 Amazon Surge Sends S&P 500, Nasdaq Higher to Start November: Stock Market Today Amazon inked a $38 billion cloud deal with OpenAI, which sent the stock to the top of the Dow Jones on Monday.
Benzinga · Nov 3, 2025 Options Corner: Kimberly-Clark's Implosion Offers An Unusual Informational Arbitrage Opportunity Kimberly-Clark Corporation (NASDAQ:KMB) rattled its shareholders when it earlier announced its acquisition of consumer goods giant Kenvue Inc (NYSE:KVUE). Ordinarily, such an acquisition might make sense due to the implied expansion of the acquiring entity's product portfolio. However, Kenvue has been ground zero for a controversy involving the flagship over-the-counter…
Barchart · Nov 3, 2025 Dear Kenvue Stock Fans, Mark Your Calendars for November 6 Upcoming earnings Kenvue stock has struggled this year, but an acquisition offer is giving investors hope leading up to this week's earnings report.
Barchart · Nov 3, 2025 Kenvue Stock Pops on News Kimberly-Clark Will Buy It for $48.7B. Is It Too Late to Buy KVUE Here? Kenvue stock soars as Kimberly-Clark agrees to acquire the consumer health giant. Jim Cramer is positive on KVUE shares heading into 2026.
Benzinga · Nov 3, 2025 Kimberly-Clark Stock Plunges Over 16%, Kenvue Surges 20% In Monday Pre-Market: What's Going On? Shares of Kimberly-Clark Corporation (NASDAQ:KMB) plunged 16.15% during the pre-market trading session on Monday, after it announced the acquisition of Kenvue Inc. (NYSE:KVUE) on Monday. Meanwhile Kenvue stock surged 20.04%.
MarketBeat · Oct 30, 2025 Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations Patience and a tolerance for risk may be necessary, but these Hold stocks could eventually see big gains, according to analysts.
Benzinga · Oct 28, 2025 Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety Texas Attorney General Ken Paxton has filed a lawsuit against Johnson Johnson (NYSE:JNJ) and Kenvue Inc (NYSE:KVUE), accusing the companies of misleading pregnant women about the safety of Tylenol despite evidence suggesting its active ingredient, acetaminophen, may increase the risk of autism and attention disorders in children.